• Publications
  • Influence
Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users.
TLDR
It can be concluded that blood pressure and body weight behaviour is similar to that seen with other low-dose OCs and the new combined pill offers excellent cycle stability and has a very favourable effect on dysmenorrhea. Expand
[Methanol, isopropanol, n-propanol--endogenous formation affected by alcohol?].
TLDR
The ethanol-induces formation of methanol and isopropanol has been described formerly and little amount of n-propanol were detected in blood, which could not be reduced to the alcoholic beverages. Expand
Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
TLDR
Significant evidence has shown that the risk of venous thromboembolism and the impact on hemostatic parameters are reduced with declining estrogen dose, and there is no evidence of a clinically significant effect of the OC progestogen doses on he mostatic parameters, but inconsistencies point to factors other than a causal relationship to explain the higher risk in users of third-generation OCs. Expand
Third- and second-generation oral contraceptives are associated with similar risk estimates for venous thromboembolism
TLDR
Population data show that the massive switch in the UK from third- Generation OCs to second-generation OCs in 1995 has not resulted in a reduction of the incidence of VTE in OC users after 1995, illustrating that the risk of V TE is not determined by the type of low-dose pill used. Expand
Health policy and third-generation oral contraceptives.
Debate. What are the risks of third-generation oral contraceptives? Health policy and third-generation oral contraceptives.
TLDR
Since it appears that prescribing patterns led to more at-risk women receiving third-generation OCs only limited evidence is available for the development of appropriate public health policy at this time. Expand
...
1
2
...